Eterna Therapeutics Inc. (ERNA)
Market Closed
16 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
6. 10
-0.2
-3.1746%
$
1.93M Market Cap
- P/E Ratio
- Div Yield
24,938 Volume
0 Eps
$ 6.3
Previous Close Want to track ERNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Eterna Therapeutics Inc. (ERNA) Statistics
Valuation metrics
Market Cap 1.93M
Enterprise value -6.86M
Trailing P/E (ttm) -0.43
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.71
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.49
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 36.38K
Average volume (90 days) 1.62M
Price summary
52-Week low 3.18
52-Week high 71.5
Beta -
50-Day moving average 8.28
200-Day moving average 15.66
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 4 May 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.08%
Return on equity -2.64%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -14.38
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 11.59
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 2.89%
Book value per share (mrq) 8.66
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
